Who Are the Leading Companies in Hematologic Malignancy Drug Development?
by Hematologic malignancies-including leukemia, lymphoma, and multiple myeloma are becoming one of the most active areas of oncology innovation. Drug development is moving beyond traditional chemotherapy …